Johnson Yiu‐Nam Lau

3.0k total citations · 2 hit papers
27 papers, 1.6k citations indexed

About

Johnson Yiu‐Nam Lau is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, Johnson Yiu‐Nam Lau has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Johnson Yiu‐Nam Lau's work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (6 papers) and COVID-19 epidemiological studies (3 papers). Johnson Yiu‐Nam Lau is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (6 papers) and COVID-19 epidemiological studies (3 papers). Johnson Yiu‐Nam Lau collaborates with scholars based in Hong Kong, China and Macao. Johnson Yiu‐Nam Lau's co-authors include S. V. Antonenko, Yong-Jun Liu, Norimitsu Kadowaki, Kang Zhang, Guangyu Wang, Chengdi Wang, Leroy F. Liu, Yuan‐Chin Tsai, Zhoufeng Wang and Weimin Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Johnson Yiu‐Nam Lau

27 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity

2000 691 citations Norimitsu Kadowaki, S. V. Antonenko et al. The Journal of Experimental Medicine profile →
COVID-19 in early 2021: current status and looking forward

2021 197 citations Chengdi Wang, Zhoufeng Wang et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Johnson Yiu‐Nam Lau Hong Kong	13	660	448	307	265	205	27	1.6k
Béatrice Laupèze Belgium	16	629 1.0×	347 0.8×	420 1.4×	182 0.7×	321 1.6×	20	1.4k
Guillaume Vogt France	20	835 1.3×	369 0.8×	469 1.5×	183 0.7×	513 2.5×	41	1.5k
Ian R. Humphreys United Kingdom	32	1.1k 1.7×	611 1.4×	539 1.8×	241 0.9×	837 4.1×	78	2.7k
J.P. Vivian Australia	28	1.6k 2.4×	632 1.4×	150 0.5×	415 1.6×	240 1.2×	55	2.6k
Beni M. Sahai Canada	14	433 0.7×	507 1.1×	195 0.6×	237 0.9×	173 0.8×	17	1.5k
Ilona Hauber Germany	26	609 0.9×	1.0k 2.3×	247 0.8×	166 0.6×	235 1.1×	51	2.0k
Xuejun Chen United States	22	588 0.9×	408 0.9×	260 0.8×	194 0.7×	316 1.5×	61	1.8k
Rosa M. Andrade United States	17	457 0.7×	262 0.6×	177 0.6×	60 0.2×	495 2.4×	25	1.5k
Shibo Jiang China	19	301 0.5×	482 1.1×	606 2.0×	100 0.4×	296 1.4×	60	1.4k
Ravit Arav‐Boger United States	28	311 0.5×	368 0.8×	435 1.4×	215 0.8×	1.2k 5.9×	88	2.0k

Countries citing papers authored by Johnson Yiu‐Nam Lau

Since Specialization

Citations

This map shows the geographic impact of Johnson Yiu‐Nam Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnson Yiu‐Nam Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnson Yiu‐Nam Lau more than expected).

Fields of papers citing papers by Johnson Yiu‐Nam Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johnson Yiu‐Nam Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnson Yiu‐Nam Lau. The network helps show where Johnson Yiu‐Nam Lau may publish in the future.

Co-authorship network of co-authors of Johnson Yiu‐Nam Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Johnson Yiu‐Nam Lau. A scholar is included among the top collaborators of Johnson Yiu‐Nam Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johnson Yiu‐Nam Lau. Johnson Yiu‐Nam Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Jiayong, Tian Gao, Qiuzhong Pan, et al.. (2024). Phase IIA study of high-affinity TCR-T (TAEST16001) targeting NY-ESO-1 in soft tissue sarcoma.. Journal of Clinical Oncology. 42(16_suppl). 11548–11548. 1 indexed citations

Wang, Guangyu, Xiaohong Liu, Kai Wang, et al.. (2023). Deep-learning-enabled protein–protein interaction analysis for prediction of SARS-CoV-2 infectivity and variant evolution. Nature Medicine. 29(8). 2007–2018. 35 indexed citations

Lau, Johnson Yiu‐Nam, et al.. (2022). A novel galactose electrochemical biosensor intended for point-of-care measurement of quantitative liver function using galactose single-point test. Analytical and Bioanalytical Chemistry. 414(14). 4067–4077. 5 indexed citations

Wang, Shuai, et al.. (2022). Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation. SHILAP Revista de lepidopterología. 1(1). e11–e11. 1 indexed citations

Wang, Chengdi, Zhoufeng Wang, Guangyu Wang, et al.. (2021). COVID-19 in early 2021: current status and looking forward. Signal Transduction and Targeted Therapy. 6(1). 114–114. 197 indexed citations breakdown →

Lau, Lok Ting, et al.. (2021). COVID-19 Delta variants—Current status and implications as of August 2021. Precision Clinical Medicine. 4(4). 287–292. 16 indexed citations

Tian, Min, et al.. (2020). Rational design, engineer, and characterization of a novel pegylated single isomer human arginase for arginine depriving anti-cancer treatment. Life Sciences. 264. 118674–118674. 10 indexed citations

Zhang, Kang, Weiwei Tong, Xinghuan Wang, & Johnson Yiu‐Nam Lau. (2020). Estimated prevalence and viral transmissibility in subjects with asymptomatic SARS-CoV-2 infections in Wuhan, China. Precision Clinical Medicine. 3(4). 301–305. 3 indexed citations

Hou, Fan Fan, Fuling Zhou, Xin Xu, et al.. (2020). Personnel protection strategy for healthcare workers in Wuhan during the COVID-19 epidemic. Precision Clinical Medicine. 3(3). 169–174. 7 indexed citations

10.

Lau, Johnson Yiu‐Nam, et al.. (2019). Eribulin ORA: A novel oral formulation of eribulin based on combination with the P-gp inhibitor HM30181A.. Journal of Clinical Oncology. 37(15_suppl). e12577–e12577. 1 indexed citations

11.

Lau, Johnson Yiu‐Nam, et al.. (2018). Pharmacokinetic and Pharmacodynamic Evaluation of Different PEGylated Human Interleukin-11 Preparations in Animal Models. Journal of Pharmaceutical Sciences. 107(11). 2755–2763. 1 indexed citations

12.

Lau, Johnson Yiu‐Nam, Manson Fok, Kezhi Zhang, et al.. (2018). Preclinical evaluation of the mono-PEGylated recombinant human interleukin-11 in cynomolgus monkeys. Toxicology and Applied Pharmacology. 342. 39–49. 7 indexed citations

13.

Lau, Johnson Yiu‐Nam, et al.. (2018). Efficient expression and isolation of recombinant human interleukin-11 (rhIL-11) in Pichia pastoris. Protein Expression and Purification. 146. 69–77. 9 indexed citations

14.

Wu, Jun, Rui Xu, Rixing Zhan, et al.. (2016). Effective symptomatic treatment for severe and intractable pruritus associated with severe burn-induced hypertrophic scars: A prospective, multicenter, controlled trial. Burns. 42(5). 1059–1066. 13 indexed citations

15.

Kim, Seongyeong, Ahrum Min, Kyung-Hun Lee, et al.. (2016). Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis. Cancer Research and Treatment. 49(3). 643–655. 26 indexed citations

16.

Yuen, Man‐Fung, et al.. (2001). Expression of c-Myc, c-Fos, and c-Jun in hepatocellular carcinoma. Cancer. 91(1). 106–112. 121 indexed citations

17.

Kadowaki, Norimitsu, S. V. Antonenko, Johnson Yiu‐Nam Lau, & Yong-Jun Liu. (2000). Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity. The Journal of Experimental Medicine. 192(2). 219–226. 691 indexed citations breakdown →

18.

Jordan, Ingo, Thomas Briese, Nicole Fischer, Johnson Yiu‐Nam Lau, & W. Ian Lipkin. (2000). Ribavirin Inhibits West Nile Virus Replication and Cytopathic Effect in Neural Cells. The Journal of Infectious Diseases. 182(4). 1214–1217. 144 indexed citations

19.

Lai, Ching‐Lung, et al.. (1999). Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma. Liver International. 19(5). 444–451. 22 indexed citations

20.

Lau, Johnson Yiu‐Nam. (1998). IV. Pathogenetic mechanisms involved in hepatitis C virus-induced liver diseases. American Journal of Physiology-Gastrointestinal and Liver Physiology. 275(6). G1217–G1220. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact